His chest was clear to auscultation bilaterally.
Pertinent Results: [**2159-10-15**] 08:18PM   TYPE-ART PO2-97 PCO2-30* PH-7.40 TOTAL CO2-19* BASE XS--4 INTUBATED-INTUBATED [**2159-10-15**] 08:18PM   TYPE-ART PO2-97 PCO2-30* PH-7.40 TOTAL CO2-19* BASE XS--4 INTUBATED-INTUBATED [**2159-10-15**] 06:48PM   ALT(SGPT)-20 AST(SGOT)-15 ALK PHOS-148* AMYLASE-67 TOT BILI-0.3 [**2159-10-15**] 06:48PM   WBC-5.1 RBC-3.57* HGB-10.3* HCT-29.8* MCV-83# MCH-28.9 MCHC-34.6 RDW-14.7 [**2159-10-23**] 05:13AM BLOOD WBC-3.6* RBC-3.27* Hgb-9.1* Hct-27.5* MCV-84 MCH-28.0 MCHC-33.1 RDW-13.9 Plt Ct-95* [**2159-10-23**] 05:13AM BLOOD Glucose-180* UreaN-24* Creat-1.3* Na-145 K-4.3 Cl-106 HCO3-32 AnGap-11 [**2159-10-23**] 05:13AM BLOOD ALT-23 AST-15 AlkPhos-352* TotBili-0.2  Brief Hospital Course: The patient was admitted to the [**Hospital1 18**] surgical ICU on [**2159-10-15**].
A sputum culture from HD 2 showed Pseudomonas, which was considered to be a contaminant.
On POD 4, the patient was started on Ceftazidime for presumed pneumonia diagnosed by chest X-ray and clinical presentation (low grade temperature of 100.1 and no WBC count, but increased secretions).
Medications on Admission: rapamune 5', MMF 500'''', prednisone 5', risperidol 1.5 HS, amlodipine 10', lorazepam 0.5'' PRN  Discharge Medications: 1.
Loperamide 1 mg/5 mL Liquid Sig: One (1)  PO DAILY (Daily).
Ceftazidime-Dextrose (Iso-osm) 2 g/50 mL Piggyback Sig: One (1)  Intravenous  Q12H (every 12 hours) for 8 days.
Disp:*16 32g* Refills:*0*   Discharge Disposition: Extended Care  Facility: [**Hospital3 7**] & Rehab Center - [**Hospital1 8**]  Discharge Diagnosis: respiratory failure liver failure; s/p liver transplant  Discharge Condition: stable  Discharge Instructions: Tracheostomy tube is to remain in place.
